National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
Drug Information
    Posted: 03/30/2009    Updated: 07/20/2009
Related pages
Cancer Drug Information 1

Approval Process for New Cancer Treatments 2

Access to Investigational Drugs 3
Degarelix

This page contains brief information about degarelix and a collection of links to more information about the use of this drug and ongoing clinical trials.

FDA Approved:Yes

Degarelix is approved by the Food and Drug Administration (FDA) to treat patients with advanced prostate cancer.

Degarelix is also being studied in the treatment of benign prostatic hyperplasia.

Information from the FDA

FDA Approval for Degarelix 4 - Information from the FDA about the approval of this drug and the clinical trials that led to the approval.

Information from the NCI

Definition from the NCI Drug Dictionary 5 - Detailed scientific definition and other names for this drug.

Information from the National Library of Medicine (NLM)

MedlinePlus Information on Degarelix 6 - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This NLM patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Clinical Trials

Clinical Trials for Degarelix 7 - Check for trials from NCI's PDQ Cancer Clinical Trials Registry now accepting patients.

Important: The drug information on this Web page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.




Glossary Terms

advanced cancer (ad-VANST KAN-ser)
Cancer that has spread to other places in the body and usually cannot be cured or controlled with treatment.
benign prostatic hyperplasia (beh-NINE prah-STA-tik HY-per-PLAY-zhuh)
A benign (not cancer) condition in which an overgrowth of prostate tissue pushes against the urethra and the bladder, blocking the flow of urine. Also called benign prostatic hypertrophy and BPH.
Food and Drug Administration
An agency in the U.S. federal government whose mission is to protect public health by making sure that food, cosmetics, and nutritional supplements are safe to use and truthfully labeled. The Food and Drug Administration also makes sure that drugs, medical devices, and equipment are safe and effective, and that blood for transfusions and transplant tissue are safe. Also called FDA.
prostate cancer (PROS-tayt KAN-ser)
Cancer that forms in tissues of the prostate (a gland in the male reproductive system found below the bladder and in front of the rectum). Prostate cancer usually occurs in older men.


Table of Links

1http://www.cancer.gov/cancertopics/druginfo/alphalist
2http://www.cancer.gov/clinicaltrials/learning/approval-process-for-cancer-drugs
3http://www.cancer.gov/cancertopics/factsheet/Therapy/investigational-drug-access
4http://www.cancer.gov/cancertopics/druginfo/fda-degarelix
5http://www.cancer.gov/Templates/drugdictionary.aspx?CdrID=441235
6http://www.nlm.nih.gov/medlineplus/druginfo/meds/a609022.html
7http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=441235&idtype=1